In summary, the IRE1α signaling pathway and CREBH signaling pathway can promote osteoclastogenesis, providing a new perspective for the treatment of diseases caused by osteoclast over-differentiation, such as osteoporosis. The gene discussed is CREB3L3; the disease is osteoporosis.